![](/us.svg)
Trademark: 88960596
Status Date
Monday, January 15, 2024
Filing Date
Thursday, June 11, 2020
Published for Opposition
Tuesday, October 20, 2020
Abandoned Date
Monday, January 15, 2024
5 Pharmaceuticals for treatment of pain and nausea; pharmaceuticals for treatment of opioid-induced nausea and vomiting; pharmaceuticals for treatment of migraine headaches
Jan 16, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 15, 2024
Abandonment - No Use Statement Filed
May 20, 2023
Notice Of Approval Of Extension Request E-Mailed
May 19, 2023
Sou Extension 5 Granted
May 16, 2023
Sou Extension 5 Filed
May 19, 2023
Case Assigned To Intent To Use Paralegal
May 16, 2023
Sou Teas Extension Received
Nov 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2022
Sou Extension 4 Granted
Nov 28, 2022
Sou Extension 4 Filed
Nov 28, 2022
Sou Teas Extension Received
Jun 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 1, 2022
Sou Extension 3 Granted
Jun 1, 2022
Sou Extension 3 Filed
Jun 1, 2022
Sou Teas Extension Received
Dec 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2021
Sou Extension 2 Granted
Dec 9, 2021
Sou Extension 2 Filed
Dec 9, 2021
Sou Teas Extension Received
Jun 1, 2021
Notice Of Approval Of Extension Request E-Mailed
May 28, 2021
Sou Extension 1 Granted
May 28, 2021
Sou Extension 1 Filed
May 28, 2021
Sou Teas Extension Received
Dec 15, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 20, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 20, 2020
Published For Opposition
Sep 30, 2020
Notification Of Notice Of Publication E-Mailed
Sep 15, 2020
Approved For Pub - Principal Register
Sep 15, 2020
Examiner's Amendment Entered
Sep 15, 2020
Notification Of Examiners Amendment E-Mailed
Sep 15, 2020
Examiners Amendment E-Mailed
Sep 15, 2020
Examiners Amendment -Written
Sep 14, 2020
Assigned To Examiner
Jul 9, 2020
New Application Office Supplied Data Entered
Jun 15, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24